First patient implanted with Philips' Duo Venous stent system [Yahoo! Finance]
AngioDynamics' (ANGO) AlphaVac System Gets CE Mark Approval [Yahoo! Finance]
Investors in AngioDynamics (NASDAQ:ANGO) have unfortunately lost 75% over the last three years [Yahoo! Finance]
AngioDynamics, Inc. (NASDAQ: ANGO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
AngioDynamics receives CE Mark approval in Europe for AlphaVac F1885 System [Seeking Alpha]